IGM Biosciences, Inc. Insider Trading for September 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IGM Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IGM Biosciences, Inc. for September 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 950 | 1,321 | 358,240 | |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 77.91 | 609 | 47,447 | 116,518 | 117.1 K to 116.5 K (-0.52 %) |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 71.14 | 341 | 24,259 | 117,127 | 117.5 K to 117.1 K (-0.29 %) |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 950 | 1,321 | 117,468 | 116.5 K to 117.5 K (+0.82 %) |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 950 | 1,321 | 358,240 | |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 77.91 | 609 | 47,447 | 116,518 | 117.1 K to 116.5 K (-0.52 %) |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 71.14 | 341 | 24,259 | 117,127 | 117.5 K to 117.1 K (-0.29 %) |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 950 | 1,321 | 117,468 | 116.5 K to 117.5 K (+0.82 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 64.80 | 1,570 | 101,729 | 93,214 | 91.6 K to 93.2 K (+1.71 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 63.58 | 3,351 | 213,044 | 91,644 | 88.3 K to 91.6 K (+3.80 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 63.06 | 2,791 | 176,004 | 88,293 | 85.5 K to 88.3 K (+3.26 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 61.80 | 4,336 | 267,984 | 85,502 | 81.2 K to 85.5 K (+5.34 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 60.86 | 5,033 | 306,333 | 81,166 | 76.1 K to 81.2 K (+6.61 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 59.65 | 4,442 | 264,948 | 76,133 | 71.7 K to 76.1 K (+6.20 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 58.75 | 5,132 | 301,511 | 71,691 | 66.6 K to 71.7 K (+7.71 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 57.75 | 2,367 | 136,691 | 66,559 | 64.2 K to 66.6 K (+3.69 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 56.41 | 978 | 55,165 | 64,192 | 63.2 K to 64.2 K (+1.55 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Sell | S | 60.00 | 1,000 | 60,000 | 2,896 | 3.9 K to 2.9 K (-25.67 %) |
| Sep 09 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 51.85 | 8,650 | 448,523 | 3,425,811 | 3.4 M to 3.4 M (+0.25 %) |
| Sep 09 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 52.96 | 14,610 | 773,811 | 3,417,161 | 3.4 M to 3.4 M (+0.43 %) |
| Sep 09 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 49.91 | 47,113 | 2,351,504 | 3,402,551 | 3.4 M to 3.4 M (+1.40 %) |
| Sep 09 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 50.28 | 74,433 | 3,742,186 | 3,355,438 | 3.3 M to 3.4 M (+2.27 %) |
| Sep 09 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 50.20 | 602 | 30,220 | 116,518 | 117.1 K to 116.5 K (-0.51 %) |
| Sep 03 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 48.69 | 74,253 | 3,615,208 | 3,281,005 | 3.2 M to 3.3 M (+2.32 %) |
| Sep 03 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 46.76 | 19,173 | 896,593 | 3,206,752 | 3.2 M to 3.2 M (+0.60 %) |
| Sep 03 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 45.54 | 1,464 | 66,674 | 3,187,579 | 3.2 M to 3.2 M (+0.05 %) |
| Sep 03 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 44.84 | 41,759 | 1,872,327 | 3,186,115 | 3.1 M to 3.2 M (+1.33 %) |
| Sep 03 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 950 | 1,321 | 359,190 | |
| Sep 03 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 44.77 | 348 | 15,580 | 117,120 | 117.5 K to 117.1 K (-0.30 %) |
| Sep 03 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 950 | 1,321 | 117,468 | 116.5 K to 117.5 K (+0.82 %) |